imiquimod has been researched along with Pemphigus in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (60.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Authors | Studies |
---|---|
Hasbun, MT; Hussain, SH; Jones, KM; Schmidt, BAR; Zhong, CS | 1 |
Amagai, M; Iriki, H; Ito, H; Kurebayashi, Y; Mukai, M; Takahashi, H | 1 |
Sayama, K; Shiraishi, K | 1 |
Brunetti, G; Cozzi, R; Lo Schiavo, A; Puca, RV; Ruocco, E; Sangiuliano, S | 1 |
Bauza, A; Del Pozo, LJ; Martin, A; Saus, C | 1 |
Edmonds, J; Marr, PJ; Martin, LK; Murrell, DF; Pas, HH; Rubin, AI; Sebaratnam, DF; Tran, K | 1 |
Campagne, G; MartÃnez, A; Roca, M | 1 |
Baroni, A; Rossiello, L; Ruocco, E; Ruocco, V | 1 |
Ladd, DJ; Lin, R; Powell, DJ; Way, BV | 1 |
Brenner, S; Mashiah, J | 1 |
10 other study(ies) available for imiquimod and Pemphigus
Article | Year |
---|---|
Pemphigus-like eruption as a complication of molluscum contagiosum treatment with imiquimod in a 5-year-old girl.
Topics: Adjuvants, Immunologic; Child, Preschool; Drug Eruptions; Female; Humans; Imiquimod; Molluscum Contagiosum; Pemphigus | 2020 |
Imiquimod-induced dermatitis impairs thymic tolerance of autoreactive CD4
Topics: Animals; CD4-Positive T-Lymphocytes; Dermatitis, Allergic Contact; Desmoglein 3; Disease Models, Animal; Humans; Imiquimod; Immune Tolerance; Mice; Mice, Knockout; Pemphigus; Skin; Thymus Gland | 2020 |
Pemphigus foliaceus induced by topical imiquimod treatment.
Topics: Adjuvants, Immunologic; Administration, Oral; Administration, Topical; Anti-Inflammatory Agents; Complement C3; Humans; Imiquimod; Immunoglobulin G; Keratosis, Actinic; Male; Middle Aged; Pemphigus; Prednisone; Treatment Outcome | 2018 |
Contact pemphigus: a side-effect of imiquimod therapy.
Topics: Administration, Topical; Aminoquinolines; Azathioprine; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluorescent Antibody Technique, Direct; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Methylprednisolone; Middle Aged; Papillomaviridae; Papillomavirus Infections; Pemphigus; Prednisone; Risk Assessment; Treatment Outcome; Vulvar Diseases | 2008 |
Pemphigus-like lesions induced by imiquimod.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Eruptions; Female; Humans; Imiquimod; Middle Aged; Pemphigus; Skin Neoplasms | 2009 |
Reversible relapse of pemphigus foliaceus triggered by topical imiquimod suggests that Toll-like receptor 7 inhibitors may be useful treatments for pemphigus.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Middle Aged; Pemphigus; Skin Neoplasms; Toll-Like Receptor 7; Treatment Outcome | 2011 |
Successful treatment of a high-grade intraepithelial neoplasia with imiquimod, with vulvar pemphigus as a side effect.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Genital Neoplasms, Female; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Pemphigus; Treatment Outcome; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Diseases; Vulvar Neoplasms | 2003 |
Imiquimod contact pemphigus: a comment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Clobetasol; Contraceptives, Oral; Female; Humans; Imiquimod; Papillomavirus Infections; Pemphigus; Treatment Outcome; Vulvar Diseases; Vulvar Neoplasms | 2004 |
Localized pemphigus foliaceus induced by topical imiquimod treatment.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diagnosis, Differential; Drug Eruptions; Face; Facial Dermatoses; Female; Humans; Imiquimod; Middle Aged; Pemphigus; Skin Neoplasms | 2004 |
Possible mechanisms in the induction of pemphigus foliaceus by topical imiquimod treatment.
Topics: Administration, Topical; Aminoquinolines; Cytokines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imiquimod; Interferons; Male; Pemphigus; Risk Assessment; Sampling Studies | 2005 |